Multiple primary malignancies of the liver and the colon: a complex diagnostic and decisional process with a final unanswered question
© Portolani et al.; licensee BioMed Central Ltd. 2014
Received: 6 July 2013
Accepted: 29 January 2014
Published: 29 March 2014
We herein present the case of a 78-year-old man with an incidental finding of a solid hepatic mass without symptoms and only a laparotomic cholecystectomy for acute cholecystitis in the past surgical history. A colonoscopy, a magnetic resonance imaging scan, a positron emission tomography scan, and a computed tomography scan completed the preoperative workup: a neoplastic lesion 4.3 × 3 cm in size was diagnosed at segments IV and V, associated with a neoplastic involvement of the splenic flexure without signs of colonic occlusion. After colonic resection, a frozen section on a granulomatous-like tissue at gastric border suggested a diagnosis of an adenocarcinoma of bilio-pancreatic type, changing the surgical strategy to include gastric resection and hepatic pedicle node dissection. The discussion turns around the idea that a final diagnosis of colon cancer with regional nodal involvement (pT3N1) and metastatic gallbladder cancer with multiple peritoneal seedings cannot be excluded.
Preoperative distinction between primary or metastatic cancer has to be as accurate as possible for hepatic lesions, because the treatment is generally different.
CT and MRI are considered the best imaging techniques for cancer staging and surgical strategy guiding; they can also lead to a strong suspicion of hepatocellular carcinoma, that is, through the vascular pattern evaluation, suggesting to go straight to surgery. When a certain preoperative differential diagnosis between colonic metastasis and ICC is not possible, further investigations are mandatory.
A 78-year-old man was admitted to our ward for the incidental finding at the ultrasound of a solid mass in the liver, without symptoms. His past surgical history consisted of only a laparotomic cholecystectomy for acute cholecystitis, with a liver biopsy diagnostic for aggressive chronic hepatitis (the patient was HBV and anti HCV negative). The patient was in good general condition, but significant morbidity was noted: chronic renal failure (creatinine value 1.4 mg/dl), chronic obstructive pulmonary disease, hypertension, and a recent asymptomatic myocardial infarction. The liver function was normal. At the computed tomography (CT) scan, a 4.3 × 3 cm neoplastic lesion was found in segments IV and V. There was no macroscopic involvement of portal tree and hepatic artery. Magnetic resonance imaging (MRI) showed the main lesion with a cystic or necrotic central portion and a peripheral enhancement with late pooling; a little satellite nodule was also discovered. Imaging was suggestive either for a peripheral intrahepatic cholangiocarcinoma or for a liver metastasis from an occult cancer, probably arising from the gastroenteric tract. Tumor markers seemed to support this last hypothesis: CEA, 30 ng/mL; Ca, 19-9 > 12,000 U/mL; and alpha phetoprotein 3 UI/mL, strongly suggestive for a cancer arising from a secretory epithelium. An 18 F-FDG PET scan showed captation in the previously described sites (liver and colon), without any other visible spots. Colonoscopy showed a neoplastic stenosis in the transverse colon, limiting the direct visualization of the right colon. A CT colonoscopy confirmed the neoplastic involvement of the splenic flexure without signs of colonic occlusion and our endoscopic biopsy was positive for adenocarcinoma.
With a preoperative diagnosis of colon cancer with synchronous liver metastasis, the clinical case was evaluated by a multidisciplinary team. The age of the patient, the chronic liver failure, and the recent acute coronary syndrome were considered by the oncologist as contraindications to chemotherapy, neoadjuvant nor palliative. A further cardiologic evaluation showed no contraction of the infero-posterior part of the myocardium with a slight reduction of the ejection fraction (40%). Myocardial scintigraphy showed a stable hypoperfusion in the corresponding zone and a limited reversible hypoperfusion at the inferior portion of the septum; the dipiridamol test was negative for ischemic signs and symptoms. The patient was considered by the cardiologist at low to medium risk of a severe ischemic accident in the postoperative period. The anesthesiologist defined an increased risk for surgery with an ASA score of 3 (American Society of Anesthesiologists’ score).
A synchronous segmental colonic and liver resection was planned.
The intraoperative evaluation confirmed the splenic flexure neoplasia with a single hepatic lesion, lying in the gallbladder fossa with an extensive gastric adhesion. No ascites and no macroscopic nodal involvement were evident. Intraoperative ultrasound was negative for further hepatic lesions.
On postoperative day 2 an asymptomatic myocardial infarction occurred, requiring a short recovery in the Intensive Coronary Care Unit of without any specific therapeutic care other than endovenous heparin. No surgical complications were recorded. The patient was discharged on postoperative day 20.
At this point, we reconsidered the past surgical history (urgent cholecystectomy 4 years before): the operating report described a difficult surgery, the gallbladder being removed after a wide opening of the wall. A pathology re-evaluation confirmed the initial diagnosis of acute necrotic ulcerative cholecystitis with slight dysplasia.
Three months after surgery, a diffuse abdominal recurrence (liver, spleen, adrenal gland, and mesenteric nodes) was noted. The patient died 9 months after surgery.
For a differential diagnosis, two different strategies are feasible: exclusion of a gastroenteric origin of the tumor by colonscopy and gastroscopy, or doing a percutaneous biopsy (PB). For PB, in addition to technical problems due to reaching the lesion (this was not our case) and the specific risks of the procedure, some diagnostic difficulties can arise for the pathologist, given that different lesions share similar histological aspects. Therefore, an endoscopic study of the gastroenteric tract is considered the main diagnostic tool and when a primary colonic cancer is discovered, the diagnosis is generally considered certain (colonic cancer with a synchronous liver metastasis), and PB is usually not performed.
The following step is the definition of a therapeutic strategy, either immediate surgery (synchronous colonic and liver resection) or sequential therapy, where colonic resection, liver resection, and chemotherapy are differently combined in every single patient.
However, multiple synchronous neoplasms cannot be excluded a priori: colonic and biliary cancer association is rare but previously described and carries some diagnostic and therapeutic problems. The first one, as above mentioned, is the difficulty to get a certain preoperative diagnosis, because the presence of a secretory epithelium histology does not allow you to differentiate the colonic mucosa from the biliary tract. Immunohistochemical tests can help for differential diagnosis, but the global accuracy of this method (expensive and time-consuming) is not complete when applied on small specimens. Intraoperative evaluation also has some limitations, that is, considering that ICC and colonic metastases can be macroscopically similar, mostly due to the high percentage of fibrosis. In our case, only the intraoperative frozen examination allowed us making the diagnosis of multiple primary neoplasms; the ab extrinseco neoplastic involvement of the gastric wall (with normal mucosa) and the adhesion to the liver suggested an invasion by continuity from a primary liver cancer. This diagnosis changed our surgical strategy: ICC in our current practice requires hepatic pedicle node dissection, in particular for lesions larger than 5 cm; according to neoplastic finding on gastric wall, a gastric resection instead of simple adhesiolysis was mandatory.
During gastric dissection, some free biliary stones showed up and this was the clear demonstration that the gallbladder had been violated during the previous cholecistectomy. This finding gives way to an intriguing hypothesis: the ‘biliary’ cancer may have been a gallbladder cancer and not a peripheral intrahepatic cholangiocarcinoma. In favor of this diagnosis the cancer was located in the gallbladder fossa and macroscopically the adhesion with the stomach seemed not to be a direct infiltrative growth of the tumor but a kind of easily fragmentable tissue with neoplastic involvement, as one can expect for an initially adhesive process with a subsequent neoplastic colonization. Furthermore, multiple micro-localization spread (perigastric, omentum, and pelvic peritoneum) would be expected after the dissemination of cancer cells and an iatrogenic perforation of the gallbladder is a well described possible etiologic mechanism, given that this is the principal concern to a laparoscopic approach when a significant risk of malignancy is supposed[4, 5]. On the other hand, the long period of time between cholecystectomy and our intervention (almost 4 years) and the negativity of the pathology are against this hypothesis.
Gallbladder cancer is an interesting model of a step-by-step process with fixed progression time: after a first phase of metaplasia and low dysplasia, the evidence of an early cancer takes generally more than 12 years to show, while the passage to an advanced cancer takes only about 2 years; at this time the natural history of cancer is very quick, with a mean life expectancy of 3 to 6 months. In the majority of cases, the process is clinically silent. Most gallbladder carcinomas originate in the mucosa as de novo carcinoma and the adenoma-carcinoma sequence has little importance in the histogenesis of this kind of cancer.
In the presence of an early stage cancer, histology is not rarely considered negative by expert pathologists[7, 8]. Diagnostic dilemmas are particularly evident when the inflammatory alterations are prevalent; furthermore, usually in these situations no exhaustive evaluations of the specimen are performed, because without a clear cancer only two to three suspicious samplings from the different portions of the gallbladder are routinely done. Finally, the rapid re-growth of cancer with a diffuse metastatization pattern supports the hypothesis of gallbladder cancer. According to these considerations, a final diagnosis of colon cancer with regional nodal involvement (pT3N1) and metastatic gallbladder cancer with multiple peritoneal seedings cannot be excluded.
Written informed consent was obtained from the patient for publication of this paper. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Authors thank Mr. Ezio Melgazzi for photo editing.
- Kim SE, Lee HC, Shim JH, Park HJ, Kim KM, Kim PN, Shin YM, Yu ES, Chung YH, Suh DJ: Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2 cm in a hepatitis B virus-endemic area. Liver Int. 2011, 31: 1468-1476. 10.1111/j.1478-3231.2011.02529.x.View ArticlePubMedGoogle Scholar
- Montella M, Buzzoni C, Crispo A: Epidemiology: data from Cancer Registries. Multiple Primary Malignancies. 2009, Milan: Springer, 7-26.View ArticleGoogle Scholar
- Portolani N, Baiocchi GL, Coniglio A, Piardi T, Grazioli L, Benetti A, Ferrari Bravo A, Giulini SM: Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Ann Surg Oncol. 2008, 15: 1880-1890. 10.1245/s10434-008-9933-y.View ArticlePubMedGoogle Scholar
- Kaushik SP: Current perspectives in gallbladder carcinoma. J Gastroenterol Hepatol. 2001, 16: 848-854. 10.1046/j.1440-1746.2001.02520.x.View ArticlePubMedGoogle Scholar
- Shirai Y, Ohtani T, Hatakeyama K: Laparoscopic cholecystectomy may disseminate gallbladder carcinoma. Hepatogastroenterology. 1998, 45: 81-82.PubMedGoogle Scholar
- de Aretxabala X, Roa I, Araya JC, Burgos L, Flores P, Huenchullan I, Miyazaki I: Operative findings in patients with early forms of gallbladder cancer. Brit J Surg. 1990, 77: 291-293. 10.1002/bjs.1800770316.View ArticlePubMedGoogle Scholar
- Roa I, Araya JC, Villaseca M, Roa J, de Aretxabala X, Ibacache G: Gallbladder cancer in a high risk area: morphological features and spread patterns. Hepatogastroenterology. 1999, 46: 1540-1546.PubMedGoogle Scholar
- Yamaguchi K, Tsuneyoshi M: Subclinical gallbladder carcinoma. Am J Surg. 1992, 163: 382-386. 10.1016/0002-9610(92)90038-S.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.